XML 43 R34.htm IDEA: XBRL DOCUMENT
v3.25.3

Investment in MiNK Therapeutics, Inc. (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Investment Company [Abstract] |
Summarized Balance Sheet Information and Results of Operations | The following tables present summarized balance sheet information as of September 30,2025 and summarized results of operations for the three months since the date of deconsolidation (in thousands):
|  | September 30, 2025 |
Current assets |  | $ | 14,534 |
Non-current assets |  |  | 429 |
Current liabilities |  |  | 13,434 |
Non-current liabilities |  |  | 15,043 |
|  | Three Months Ended September 30, |
|  | 2025 |
Net loss |  | $ | (2,888 | )
Net loss attributable to Agenus |  |  | (1,386 | )

X
- References No definition available. + Details
Name: | us-gaap_InvestmentCompanyAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of summarized financial information for nonconsolidated subsidiary of investment company. Excludes information consolidated by reporting entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 + Details
Name: | us-gaap_InvestmentCompanyNonconsolidatedSubsidiarySummarizedFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration